Best NanoKnife Doctors Worldwide — TOP 33

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Dr. Solak specializes in treating various cancers, including breast, lung, and gastrointestinal cancers, with extensive training at top institutions.

• Completed fellowship at Hacettepe University Cancer Institute
• Trained at The University of Texas MD Anderson Cancer Center
• Specializes in breast, testicular, ovarian, and head-neck cancers
• Works at Hisar Hospital Intercontinental

Leading expert in NanoKnife technology with a focus on thoracic malignancies and innovative genomic profiling at Sourasky Medical Center.

• Senior Lecturer and PI for multiple clinical trials in oncology
• Specializes in intra-tumoral injections and comprehensive genomic profiling
• Member of ESMO and IASLC with extensive research in lung cancer
• Outstanding teacher recognized by Tel-Aviv University

Professor Nagler pioneered reduced-intensity allogeneic transplantations – a gentler approach for high-risk patients at Sheba Medical Center.

• 35+ years in hematology and bone marrow transplantation
• Founder of Israel's first public cord blood bank
• Former chair of EBMT's Acute Leukemia Working Party
• Board-certified in internal medicine and hematology
• Trained at Stanford University Hospital

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Specializes in robotic and laparoscopic surgeries, including advanced procedures like Robotic Radical Prostatectomy and Laparoscopic Sacrocolpopexy at İstinye University Liv Hospital Topkapı.

• Over 29 years of experience of experience in urology
• Trained at S.B. Ankara Training and Research Hospital
• Expert in Robotic Radical Cystectomy and HOLEP Surgery
• Performs all types of female incontinence surgeries

Specializes in minimally invasive robotic prostatectomy using the da Vinci system.

• Trained at Johns Hopkins Hospital.
• Performs 500+ procedures annually.
• Board-certified in urologic oncology.

Dr. Barak Rosenzweig directs the Urological Oncology Service at Sheba Medical Center in Israel. He is a surgeon who has been listed among Israel’s Best Doctors by Forbes. Dr. Rosenzweig specializes in treating tumors of the prostate, kidney, bladder, and testis. He focuses on robotic and minimally invasive cancer surgery to preserve organ function.

• Completed a Urological Oncology fellowship at Memorial Sloan Kettering Cancer Center.
• Performs robotic radical prostatectomy and kidney-sparing partial nephrectomy.
• Clinical Senior Lecturer at Tel Aviv University with over 200 scientific publications.
• Uses MRI-guided fusion biopsy for high-precision prostate cancer detection.

Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).

He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.

Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Dr. Son Dong-wan specializes in urologic oncology, urinary incontinence, and sexual dysfunction. He performs laser prostate surgery. He provides robotic and laparoscopic treatment for cancers of the prostate, bladder, ureter, and kidney. He also treats ureteropelvic junction obstruction.

His minimally invasive practice includes laparoscopic nephrectomy and prostatectomy. He performs cystoscopic TURBT and TURP. He offers ureteroscopic laser stone removal and percutaneous nephrolithotomy. He treats BPH, prostatitis, urinary stones, testicular cancer, stress urinary incontinence (SUI), overactive bladder (OAB), and male infertility.

Prof. Jack Baniel specializes in nerve-sparing cancer surgeries and robotic prostatectomy, with over 100 published scientific articles in uro-oncology.

• Chief of Urology at Rabin Medical Center
• Founder of the oncourological Department at Beilinson Hospital
• Member of multiple international urology research organizations
• Participates in global-scale clinical research

Associate Professor Tahsin Ozatli specializes in breast, lung, and gastrointestinal cancers at Istinye Liv University Hospital.

• Over a decade of experience in oncology
• Worked at Ankara Oncology Clinic and Erzurum Regional Training and Research Hospital
• Promoted to Associate Professor in 2016

Dr. Alemdar specializes in Medical Oncology with extensive training at Akdeniz University – a leader in cancer care.

• Board-certified in Medical Oncology since 2018
• Over 20 years of experience of experience in oncology
• Works at Medical Park Antalya Hospital Complex

Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.

• Chair of the Israel Lung Cancer Group.
• Board-certified in both Medical Oncology and Radiotherapy Oncology.
• Treats patients at Sheba Medical Center, a top-10 globally ranked hospital.
• Uses molecular and genetic profiling to create precise cancer treatment plans.

Dr. Yaacov Lawrence is the Chair of Radiation Oncology at Sheba Medical Center. He specializes in precision radiation therapy and neuro-oncology. Dr. Lawrence pioneered celiac plexus radiosurgery for pancreatic cancer pain management. He holds the FASTRO designation, one of the highest honors in his specialty.

• Leads the Gastrointestinal Cancer Program at Sheba Medical Center.
• Performs stereotactic radiosurgery for brain tumors and nervous system cancers.
• Authored over 280 scientific publications on personalized radiation protocols.
• Completed radiation oncology fellowship training at Thomas Jefferson University.

Dr. Dorit Zilberman is a senior urologist at Sheba Medical Center in Israel. She is a pioneer of robotic and minimally invasive urologic surgery. Dr. Zilberman treats kidney, bladder, and prostate cancers. She helped launch the da Vinci robotic surgery program at Sheba. Forbes Israel recognized her among the nation's best doctors.

• Authored over 160 scientific publications in urologic oncology and endourology.
• Completed fellowship training at Duke University Medical Center in the US.
• Performs robotic prostatectomy, laser lithotripsy, and kidney-sparing surgery.
• Member of the American and European Urological Associations and the Endourological Society.